These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1346763)

  • 21. A chimeric EGFR/neu receptor in functional analysis of the neu oncoprotein.
    Lehtola L; Lehväslaiho H; Koskinen P; Alitalo K
    Acta Oncol; 1992; 31(2):147-50. PubMed ID: 1352454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The single transmembrane domains of ErbB receptors self-associate in cell membranes.
    Mendrola JM; Berger MB; King MC; Lemmon MA
    J Biol Chem; 2002 Feb; 277(7):4704-12. PubMed ID: 11741943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of protein structure from sequence.
    Sternberg MJ; Zvelebil MJ
    Eur J Cancer; 1990; 26(11-12):1163-6. PubMed ID: 2149999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Weiner DB; Liu J; Cohen JA; Williams WV; Greene MI
    Nature; 1989 May; 339(6221):230-1. PubMed ID: 2654648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between ErbB-1 and ErbB-2 transmembrane domains in bilayer membranes.
    Sharpe S; Barber KR; Grant CW
    FEBS Lett; 2002 May; 519(1-3):103-7. PubMed ID: 12023026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformation of the transmembrane domain of the c-erbB-2 oncogene-encoded protein in its monomeric and dimeric states.
    Brandt-Rauf PW; Pincus MR; Monaco R
    J Protein Chem; 1995 Jan; 14(1):33-40. PubMed ID: 7779261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of oncogenic and cellular p185 by serine/threonine kinases.
    Dobashi K; Weiner DB; Greene MI
    DNA; 1989 Dec; 8(10):723-32. PubMed ID: 2575488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution and solid state conformation of the human EGF receptor transmembrane region.
    Rigby AC; Grant CW; Shaw GS
    Biochim Biophys Acta; 1998 May; 1371(2):241-53. PubMed ID: 9630653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A subdomain in the transmembrane domain is necessary for p185neu* activation.
    Cao H; Bangalore L; Bormann BJ; Stern DF
    EMBO J; 1992 Mar; 11(3):923-32. PubMed ID: 1347745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and activation of the Syrian hamster neu proto-oncogene.
    Nakamura T; Ushijima T; Ishizaka Y; Nagao M; Arai M; Yamazaki Y; Ishikawa T
    Gene; 1994 Mar; 140(2):251-5. PubMed ID: 7908275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmembrane domain sequence requirements for activation of the p185c-neu receptor tyrosine kinase.
    Chen LI; Webster MK; Meyer AN; Donoghue DJ
    J Cell Biol; 1997 May; 137(3):619-31. PubMed ID: 9151669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular modeling of c-erbB2 receptor dimerization: coiled-coil structure of wild and oncogenic transmembrane domains--stabilization by interhelical hydrogen bonds in the oncogenic form.
    Garnier N; Genest D; Duneau JP; Genest M
    Biopolymers; 1997 Aug; 42(2):157-68. PubMed ID: 9234995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion.
    Bargmann CI; Weinberg RA
    EMBO J; 1988 Jul; 7(7):2043-52. PubMed ID: 2901345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation.
    Samanta A; LeVea CM; Dougall WC; Qian X; Greene MI
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1711-5. PubMed ID: 7907421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of helix packing in transmembrane dimer of the cell death factor BNIP3: a molecular modeling study.
    Vereshaga YA; Volynsky PE; Pustovalova JE; Nolde DE; Arseniev AS; Efremov RG
    Proteins; 2007 Nov; 69(2):309-25. PubMed ID: 17600828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
    Weiner DB; Kokai Y; Wada T; Cohen JA; Williams WV; Greene MI
    Oncogene; 1989 Oct; 4(10):1175-83. PubMed ID: 2571965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the proto-oncogenic and mutant forms of the transmembrane region of Neu in micelles.
    Houliston RS; Hodges RS; Sharom FJ; Davis JH
    J Biol Chem; 2004 Jun; 279(23):24073-80. PubMed ID: 15051716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and membrane assembly of a transmembrane region from Neu.
    Jones DH; Ball EH; Sharpe S; Barber KR; Grant CW
    Biochemistry; 2000 Feb; 39(7):1870-8. PubMed ID: 10677238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.
    Bargmann CI; Hung MC; Weinberg RA
    Cell; 1986 Jun; 45(5):649-57. PubMed ID: 2871941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.